摘要
目的观察麦粒灸辅助沙美特罗替卡松气雾剂(舒利迭)治疗轻中度老年支气管哮喘慢性持续期的临床疗效。方法将84例轻中度老年支气管哮喘慢性持续期患者按随机数字表法随机分为观察组和对照组,每组42例。对照组予沙美特罗替卡松气雾剂治疗,每次1吸,每日2次;观察组在此基础上予麦粒灸治疗(取穴为脾俞、肺俞、膈俞),每星期2次。两组疗程均为2个月。观察治疗前后哮喘控制测试(ACT)评分、哮喘生存质量问卷(AQLQ)评分及肺功能指标(PEF、FEV1、FVC),并评价临床疗效。结果观察组总有效率为92.9%,高于对照组的78.6%,差异有统计学意义(P<0.05);两组患者治疗后ACT评分、AQLQ评分及PEF、FEV1、FVC较同组治疗前升高,差异均有统计学意义(P<0.05);组间治疗后比较,观察组改善优于对照组,差异均有统计学意义(P<0.05)。结论麦粒灸辅助沙美特罗替卡松气雾剂治疗轻中度老年支气管哮喘慢性持续期疗效确切,能有效控制哮喘程度,提高患者的生活质量。
Objective To observe the clinical efficacy of wheat-sized moxibustion in assisting the treatment of mild--to-moderate persistent chronic bronchial asthma in the elderly with Salmeterol xinafoate and fluticasone propionate aerosol. Method Eighty-four old patients with mild--to-moderate persistent chronic bronchial asthma were randomized into an observation group and a control group by using the random number table, 42 each. The control group was given Salmeterol xinafoate and fluticasone propionate aerosol, 1 inhalation each time, twice a day; the observation group was additionally given wheat-sized moxibustion by selecting Pishu （BL20）, Feishu （BL13） and Geshu （BL17）, twice a week. The two groups were both treated for 2 months. Before and after the intervention, Asthma Control Test （ACT）, Asthma Quality of Life Questionnaire （AQLQ）, and pulmonary function parameters [peak expiratory flow （PEF）, forced expiratory volume in one second （FEV1）, and forced vital capacity （FVC）] were observed, and the clinical efficacies were compared. Result The total effective rate was 92.9% in the observation group versus 78.6% in the control group, and the difference was statistically significant （P〈0,05）; the ACT and AQLQ scores, as well as PEF, FEVI and FVC were significantly increased after the intervention in both groups （P（0.05）; after the treatment, the improvement in the observation group was significantly superior to that in the control group （P〈0.05）. Conclusion Wheat-sized moxibustion is effective in assisting the treatment of mild-to-moderate persistent chronic bronchial asthma in the elderly with Salmeterol xinafoate and fluticasone propionate aerosol. It can effectively control asthma and enhance the quality of life.
作者
崔学颍
贲定严
CUI Xue-ying;BI Ding-yan(Hangzhou Hospital of Traditional Chinese Medicine,Hangzhou 3lO007,China;Hunan University of Chinese Medicine,Changsha 410208, China)
出处
《上海针灸杂志》
2017年第12期1387-1390,共4页
Shanghai Journal of Acupuncture and Moxibustion
基金
湖南省教育厅科研计划项目(13C685)
湖南省研究生科研创新项目(CX2016B351)
